Модицина². Апология (Жуков) - страница 219

Effectiveness versus efficacy of treatment of hypertension for stroke prevention. Whisnant JP. Neurology, 1996. PMID:8614485

Smoking and risk of stroke. Hankey GJ. Journal of cardiovascular risk, 1999. PMID:10501270

Smoking cessation and the risk of stroke in middle-aged men. Wannamethee SG, Shaper AG et al. JAMA, 1995. PMID:7596004

Obesity. Haslam WD, James TP. The Lancet, 2005. DOI:10.1016/S0140–6736(05)67483–1

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment. The Lancet, 1998. PMID:9742976

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study. Dormandy AJ, Charbonnel B et al. The Lancet, 2005. DOI:10.1016/S0140–6736(05)67528–9

Thrombolysis for acute ischaemic stroke. Wardlaw MJ, Murray V et al. Cochrane Stroke Group, 2014. PMC4153726

Global and regional burden of stroke during 1990–2010. Feigin LV, Forouzanfar HM et al. The Lancet, 2014. PMC4181600

Life After a Stroke. http://www.nhlbi.nih.gov/health/health-topics/topics/stroke/lifeafter

Stroke. Donnan AG, Fisher M et al. The Lancet, 2008. DOI:10.1016/S0140–6736(08)60694–7

Definition and evaluation of transient ischemic attack – AHA/ASA Scientific Statement. Stroke, 2009. DOI:10.1161/STROKEAHA.108.192218

Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial. Berge EP, Cohen G et al. The Lancet Neurology, 2016. DOI:10.1016/S1474–4422(16)30139–9

Meditation therapy for anxiety disorders. Krisanaprakornkit T, Sriraj W et al. Cochrane Common Mental Disorders Group, 2006. DOI:10.1002/14651858.CD004998.pub2

Д.А.Леонтьев «Экзистенциальная тревога и как с ней не бороться». Московский Психотерапевтический Журнал 2003, № 2

Tips to Manage Anxiety and Stress. https://www.adaa.org/tips-manage-anxiety-and-stress

Treatment of the depressive phase of bipolar affective disorder: a review. Muneer A. JPMA, 2013. PMID:23901682

Genetics of bipolar disorder. Berit Kerner. Journal of The Application of Clinical Genetics, 2014. PMC3966627

Characteristics and duration of mania: implications for continuation treatment. Steve Titmarsh. Progress in Neurology and Psychiatry, 2013. DOI:10.1002/pnp.283

Bipolar disorder and substance abuse. Robert M. Post and Peter Kalivas. The British Journal of Psychiatry, 2013. PMC4340700

Mood episodes and mood disorders. Beesdo K, Hofler M et al. Bipolar Disorders, 2009. DOI:10.1111/j.1399–5618.2009.00738.x

Psychosocial disability in the course of bipolar I and II disorders. Judd LL, Akiskal SH et al. JAMA psychiatry, 2005. DOI:10.1001/archpsyc.62.12.1322